Logo Icon
OrthoLength Pro Clinical & Patient Community
Log in Register
MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

Rare Kidney Dysplasia Guide

Va
Vaqueiro Graña M, Madariaga L,...
June 26, 2025
0 views
View on PubMed
6 min read 1,136 words kidney dysplasia symptoms Medically Reviewed

Overview

Rare kidney dysplasias, such as those associated with the TFCP2L1 gene, can have a significant impact on kidney development and function. According to a recent study (Source: PubMed), a specific variant of this gene can lead to severe kidney dysfunction and salt-wasting, mimicking other conditions like Bartter syndrome. This condition affects a small number of individuals, often those with a family history of kidney disease or consanguineous relationships.

The study examined a preterm male infant with a clinical picture of advanced kidney dysfunction and severe renal salt-wasting, which was later found to be associated with a homozygous pathogenic variant in the TFCP2L1 gene. This discovery highlights the importance of genetic diagnosis in patients with refractory courses to standard treatments.

What This Study Examined

The study delved into the clinical presentation, genetic diagnosis, and management of a patient with a rare kidney dysplasia, specifically focusing on the role of the TFCP2L1 gene in kidney development and function. The researchers aimed to understand how this gene variant affects kidney function and how it can be identified and managed in clinical practice.

Why This Matters for Patients

This study matters for patients because it underscores the importance of genetic testing in the diagnosis and management of rare kidney diseases. By identifying the underlying genetic cause of their condition, patients and their families can better understand their treatment options and make informed decisions about their care. Additionally, this knowledge can help facilitate family counseling and genetic testing for relatives who may be at risk.

Medical Background

Kidney dysplasias, including those associated with the TFCP2L1 gene, are rare conditions that affect kidney development and function. Distraction osteogenesis, a process used in bone regeneration, is not directly related to kidney dysplasias but can be an important concept in understanding the principles of tissue regeneration. In the context of kidney disease, nephrology and urology are the medical specialties that focus on the diagnosis, treatment, and management of kidney and urinary tract disorders.

How the Procedure Works

Genetic testing for the TFCP2L1 gene variant involves analyzing the patient's DNA to identify any pathogenic variants. This is typically done through a blood test or a tissue sample. Once the variant is identified, the patient's treatment plan can be tailored to address their specific needs, which may include management of electrolyte imbalance, acid-base balance, and other related complications.

Who Is a Candidate?

Candidates for genetic testing for the TFCP2L1 gene variant are typically patients who present with symptoms of kidney dysfunction, such as severe polyuria, episodes of hyponatremia, hypokalemia, and hypochloremia, and whose family history or clinical presentation suggests a possible genetic underlying cause.

Clinical Summary

  • Procedure: Genetic testing for the TFCP2L1 gene variant
  • Typical Duration: several weeks to months for testing and diagnosis
  • Recovery: variable, depending on the individual's condition and treatment plan
  • Success Rate (general): high for genetic diagnosis, but variable for treatment outcomes depending on the condition and its severity

Study Methodology

The study employed a case report design, focusing on a single patient with a rare kidney dysplasia associated with the TFCP2L1 gene variant. The patient was followed up over a period, during which their clinical presentation, genetic testing, and treatment outcomes were monitored and analyzed.

Patient Selection Criteria

The patient in this study was selected based on their clinical presentation of severe kidney dysfunction and salt-wasting, which suggested a possible genetic underlying cause. The patient's family history and consanguineous relationship also supported the decision to perform genetic testing.

Outcome Measures

The study's outcome measures included the patient's clinical response to treatment, management of electrolyte and acid-base balance, and the identification of the TFCP2L1 gene variant as the underlying cause of their condition.

Results & Findings

The study found that the patient had a homozygous pathogenic variant in the TFCP2L1 gene, which was associated with their severe kidney dysfunction and salt-wasting. The patient's clinical presentation and genetic testing results supported the diagnosis of a rare kidney dysplasia.

Key Outcomes

The key outcomes of this study included the identification of the TFCP2L1 gene variant as a cause of rare kidney dysplasia, the importance of genetic testing in the diagnosis and management of this condition, and the need for tailored treatment plans to address the specific needs of patients with this condition.

Complications & Risks

Complications and risks associated with rare kidney dysplasias, including those related to the TFCP2L1 gene variant, can include severe polyuria, episodes of hyponatremia, hypokalemia, and hypochloremia, as well as metabolic alkalosis and hyperuricemia.

Key Takeaways for Patients

  • If you or a family member is experiencing symptoms of kidney dysfunction, it is essential to discuss genetic testing with your healthcare provider to determine if a rare kidney dysplasia like the one associated with the TFCP2L1 gene variant could be the underlying cause.
  • Genetic testing can help identify the underlying genetic cause of your condition, allowing for tailored treatment plans and better management of your symptoms.
  • It is crucial to work closely with your healthcare provider to manage complications and risks associated with your condition, such as electrolyte imbalances and metabolic disturbances.

When discussing your condition with your healthcare provider, be sure to ask about the following:

  • The specific genetic cause of your condition and how it affects your kidney function
  • The treatment options available to manage your symptoms and complications
  • How to monitor and manage electrolyte and acid-base balance
  • What to expect in terms of treatment outcomes and prognosis

Frequently Asked Questions

What is a kidney dysplasia?
A kidney dysplasia is a rare condition that affects kidney development and function. It can be caused by genetic mutations, such as the TFCP2L1 gene variant, and can lead to severe kidney dysfunction and related complications.
What are the symptoms of a kidney dysplasia?
Symptoms of a kidney dysplasia can include severe polyuria, episodes of hyponatremia, hypokalemia, and hypochloremia, as well as metabolic alkalosis and hyperuricemia.
How is a kidney dysplasia diagnosed?
A kidney dysplasia is typically diagnosed through a combination of clinical evaluation, laboratory tests, and genetic testing. Genetic testing can help identify the underlying genetic cause of the condition.
What are the treatment options for a kidney dysplasia?
Treatment options for a kidney dysplasia depend on the specific cause and severity of the condition. They may include management of electrolyte and acid-base balance, as well as other supportive measures to address related complications.
Can a kidney dysplasia be inherited?
Yes, some kidney dysplasias, including those associated with the TFCP2L1 gene variant, can be inherited. Family members of individuals with a kidney dysplasia may be at risk and should discuss genetic testing with their healthcare provider.
More on: kidney dysplasia symptoms Last reviewed: August 1, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Hip Dysplasia Treatment

Overview Total hip arthroplasty (THA) is a common treatment for DDH, a condition where the hip joint doesn't form properly. Patients with high dislocation due to DDH, classified as Crowe type III or IV, face significant challenges in THA, particularly in preventing nerve complications while restoring leg length. This study examined the outcomes of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy in patients with high hip dislocation. The study matters because it provides valuable insights into the treatment of DDH, a condition that affects thousands of people worldwide. According to the study, THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy can provide favorable mid-term outcomes in patients with Crowe III/IV DDH. (Source: PubMed) What This Study Examined This study examined the clinical and radiographic outcomes of primary THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy in patients with high hip dislocation. The study aimed to identify the advantages, limitations, and possible countermeasures of this surgical approach. Why This Matters for Patients This study is important for patients with high dislocation due to DDH because it provides evidence-based information on the effectiveness and safety of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy. Patients can use this information to make informed decisions about their treatment options and to discuss their concerns with their surgeons. Medical Background DDH is a condition where the hip joint doesn't form properly, leading to hip dysplasia. THA is a surgical procedure that involves replacing the damaged or arthritic hip joint with an artificial one. In patients with high dislocation due to DDH, THA can be challenging due to the risk of nerve complications and the need to restore leg length. How the Procedure Works The procedure involves using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy to replace the damaged hip joint. The osteotomy involves cutting and realigning the femur to restore leg length and improve joint mobility. The S-ROM-A modular stem is a type of prosthesis that is designed to mimic the natural movement of the hip joint. Who Is a Candidate? Patient who have high dislocation due to DDH, classified as Crowe type III or IV, may be candidates for THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy. Patients should discuss their treatment options with their surgeons to determine if this procedure is right for them. Clinical Summary Procedure: Total hip arthroplasty (THA) using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy Typical Duration: The procedure can take several hours to complete, depending on the complexity of the case Recovery: Patients can expect to spend several days in the hospital after the procedure and several weeks or months recovering at home Success Rate (general): The success rate of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy is high, with most patients experiencing significant improvements in joint mobility and functional ability Study Methodology The study was a retrospective review of patients who underwent THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy for high dislocation due to DDH. The study included 45 hips (37 patients) with a mean age of 65 years and a mean follow-up duration of 10.7 years. Patient Selection Criteria Patient were selected based on their diagnosis of high dislocation due to DDH, classified as Crowe type III or IV. Patients who underwent THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy were included in the study. Outcome Measures The study examined the clinical and radiographic outcomes of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy, including joint mobility, functional ability, and bone union at the osteotomy site. Results & Findings The study found that THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy provided favorable mid-term outcomes in patients with Crowe III/IV DDH. The study reported a low rate of complications, including no cases of postoperative infection, symptomatic pulmonary embolism, or neurological complications in the legs. Key Outcomes The study reported significant improvements in joint mobility and functional ability after THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy. The study also reported a high rate of bone union at the osteotomy site, with no cases of nonunion except for one case that required repeat surgery. Complications & Risks The study reported a low rate of complications, including early postoperative dislocation in two hips (4%) and nonunion at the osteotomy site in one hip (2%). Repeat surgery was required in only one case of nonunion. Key Takeaways for Patients THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy can provide favorable mid-term outcomes in patients with Crowe III/IV DDH Patient should discuss their treatment options with their surgeons to determine if this procedure is right for them Patient should ask their surgeons about the potential risks and benefits of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy, including the risk of nonunion and dislocation Frequently Asked Questions What is DDH? DDH is a condition where the hip joint doesn't form properly, leading to hip dysplasia. It is a common cause of hip arthritis in young adults. What is THA? THA is a surgical procedure that involves replacing the damaged or arthritic hip joint with an artificial one. It is a common treatment for DDH and other conditions that cause hip arthritis. What is an S-ROM-A modular stem? An S-ROM-A modular stem is a type of prosthesis that is designed to mimic the natural movement of the hip joint. It is used in THA to replace the damaged or arthritic hip joint. What is oblique subtrochanteric shortening osteotomy? Oblique subtrochanteric shortening osteotomy is a surgical procedure that involves cutting and realigning the femur to restore leg length and improve joint mobility. What are the potential risks and benefits of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy? The potential benefits of THA using an S-ROM-A modular stem with oblique subtrochanteric shortening osteotomy include significant improvements in joint mobility and functional ability. The potential risks include nonunion and dislocation. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Limb Lengthening for Fibrous Dysplasia

OverviewFibrous dysplasia is a rare condition that can cause bone deformity, leading to severe antibowing of the tibia, also known as saber-shin deformity. This condition can result in significant limb-length discrepancy and bone pain. A recent study published on PubMed (Source: PubMed) demonstrated the successful use of limb lengthening using an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia.The study examined the use of asymmetric lengthening to achieve simultaneous angular realignment and limb-length restoration in an adult patient with a severe saber-shin deformity. This approach is particularly significant in resource-limited settings where more advanced technologies, such as the Taylor Spatial Frame, may not be available.Fibrous dysplasia affects approximately 1 in 4,000 to 1 in 10,000 people, and severe anterior tibial bowing is a rare but challenging complication of this condition. Patients with this condition often experience significant bone pain, limb-length discrepancy, and mobility issues.What This Study ExaminedThis study examined the use of an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia. The study demonstrated the effectiveness of asymmetric lengthening in achieving simultaneous angular realignment and limb-length restoration in an adult patient.Why This Matters for PatientsThis study is significant for patients with fibrous dysplasia who are experiencing severe anterior tibial bowing and limb-length discrepancy. The use of an Ilizarov ring fixator and asymmetric lengthening provides a practical and low-cost alternative for complex deformity correction in resource-limited settings.Medical BackgroundFibrous dysplasia is a rare condition that can cause bone deformity, leading to severe antibowing of the tibia, also known as saber-shin deformity. This condition can result in significant limb-length discrepancy and bone pain. Limb lengthening using an Ilizarov ring fixator is a surgical procedure that involves cutting and lengthening the bone to correct bone deformity and achieve limb-length restoration.Limb lengthening is a complex procedure that requires careful planning and execution. The procedure involves the use of an external fixator, such as an Ilizarov ring fixator, to stabilize and lengthen the bone. The osteotomy is performed, and the bone is gradually lengthened using a process called distraction osteogenesis.How the Procedure WorksThe limb lengthening procedure involves several steps. First, the osteotomy is performed, and the bone is cut and prepared for lengthening. The Ilizarov ring fixator is then applied, and the bone is gradually lengthened using distraction osteogenesis. This process can take several months to complete, and the patient must undergo regular follow-up appointments to monitor the progress of the lengthening.Who Is a Candidate?Patients with severe anterior tibial bowing secondary to fibrous dysplasia may be candidates for limb lengthening using an Ilizarov ring fixator. The procedure is typically recommended for patients who have significant limb-length discrepancy and bone pain that is not responsive to conservative treatment. Patients must be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program to achieve optimal results.Clinical SummaryProcedure: Limb lengthening using an Ilizarov ring fixatorTypical Duration: Several months to complete the lengthening processRecovery: Prolonged period of rehabilitation and follow-up appointments to monitor the progress of the lengtheningSuccess Rate (general): High success rate for achieving significant limb-length restoration and correcting bone deformityStudy MethodologyThe study was a case report that examined the use of an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia in an adult patient. The patient underwent two tibial osteotomies proximal and distal to the apex of the deformity, and an Ilizarov ring construct was applied without hinge mechanisms. The patient underwent progressive adjustment of the Ilizarov ring fixator to achieve satisfactory angular realignment and near-complete limb-length restoration.Patient Selection CriteriaThe patient was selected for the study based on the presence of severe anterior tibial bowing secondary to fibrous dysplasia and significant limb-length discrepancy. The patient was also required to be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program.Outcome MeasuresThe outcome measures for the study included the degree of angular realignment and limb-length restoration achieved, as well as the presence of any complications or adverse events. The patient was followed up for a period of several months to monitor the progress of the lengthening and to assess the final outcome.Results & FindingsThe study demonstrated the successful use of an Ilizarov ring fixator to correct extreme anterior tibial bowing secondary to fibrous dysplasia in an adult patient. The patient achieved satisfactory angular realignment and near-complete limb-length restoration, with a significant reduction in bone pain and improvement in mobility.Key OutcomesThe key outcomes of the study included the degree of angular realignment and limb-length restoration achieved, as well as the presence of any complications or adverse events. The patient experienced no significant complications or adverse events during the study period, and the final outcome was considered to be excellent.Complications & RisksAs with any surgical procedure, there are potential complications and risks associated with limb lengthening using an Ilizarov ring fixator. These may include osteomyelitis, neurological damage, and malunion or nonunion of the osteotomy site. Patients must be carefully selected and monitored to minimize the risk of these complications.Key Takeaways for PatientsPatient with severe anterior tibial bowing secondary to fibrous dysplasia may be candidates for limb lengthening using an Ilizarov ring fixatorThe procedure can achieve significant limb-length restoration and correction of bone deformityPatients must be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program to achieve optimal resultsPatients should ask their surgeon about the potential risks and complications of the procedure, as well as the expected outcome and rehabilitation requirementsPatient should also ask their surgeon about the following:What is the expected duration of the distraction osteogenesis process?What are the potential risks and complications of the procedure?What is the expected outcome and how will it be measured?What is the rehabilitation program and how long will it last?Frequently Asked QuestionsWhat is fibrous dysplasia?Fibrous dysplasia is a rare condition that can cause bone deformity, leading to severe antibowing of the tibia, also known as saber-shin deformity. It is a genetic disorder that affects the development of the bone and can cause a range of symptoms, including bone pain, limb-length discrepancy, and mobility issues.What is limb lengthening?Limb lengthening is a surgical procedure that involves cutting and lengthening the bone to correct bone deformity and achieve limb-length restoration. It is typically performed using an external fixator, such as an Ilizarov ring fixator, to stabilize and lengthen the bone.What is an Ilizarov ring fixator?An Ilizarov ring fixator is a type of external fixator that is used to stabilize and lengthen the bone during limb lengthening. It is a circular device that is attached to the bone using wires and pins, and is used to apply a gradual and controlled force to the bone to achieve limb-length restoration and correction of bone deformity.What are the potential risks and complications of limb lengthening?As with any surgical procedure, there are potential risks and complications associated with limb lengthening. These may include osteomyelitis, neurological damage, and malunion or nonunion of the osteotomy site. Patients must be carefully selected and monitored to minimize the risk of these complications.How long does the distraction osteogenesis process take?The distraction osteogenesis process can take several months to complete, depending on the degree of limb-length restoration required and the individual patient's response to the procedure. Patients must be willing and able to undergo a prolonged period of distraction osteogenesis and follow a rigorous rehabilitation program to achieve optimal results.What is the rehabilitation program like after limb lengthening?The rehabilitation program after limb lengthening is typically rigorous and requires a significant amount of time and effort from the patient. Patients must undergo regular physical therapy sessions to maintain range of motion and strength in the affected limb, and must also follow a strict program of rehabilitation exercises to achieve optimal results. The rehabilitation program can last for several months to a year or more, depending on the individual patient's needs and response to the procedure. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks Advancements in Hip Surgery: A Comprehensive Guide for Patients Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy

Read Full Summary →